Abstract
Meningioma is the most common type of the central nervous system tumor. South East Asia is the third highest cases of central nervous system tumor with 190,376 cases every year. The majority of meningioma cases are benign, although few of the cases requires a lot more significant treatment in order to survive. Although meningiomas with complicated histopathology and/or in tricky locations can be challenging for surgeons to treat. The earlier we detect and handle brain tumor, the better the prognosis outcome for the patient. Method used in this paper is literature review. Review made by finding and curating literatures regarding meningioma on online databases such as PubMed, Google Scholar, and Proquest. This paper summarizes the current epidemiology, etiology, histopathology, pathology, diagnosis, and the current treatments available for meningioma.
Keywords:
Benign tumor, meningioma, pathofisiology.References
Ahrendsen, J. dan Alexandrescu, S. (2022) Pathology Outline – WHO Grading of meningiomas.
Al-Mefty., Ossama., McDermott, Michael, W, DeMonte, & Franco. (2011). Al-Mefty’s Meningiomas Second Edition (2nd ed.). Thieme Medical.
Alruwaili, A.A. dan de Jesus, O. (2022) Meningioma, CyberKnife Stereotactic Radiosurgery: Brain. StatPearls Publishing.
Bell, J. S., Koffie, R. M., Rattani, A., Dewan, M. C., Baticulon, R. E., Qureshi, M. M., Wahjoepramono, E. J., Rosseau, G., Park, K., & Nahed, B. v. (2019). Global incidence of brain and spinal tumors by geographic region and income level basedon cancer registry data. Journal of Clinica l Neuroscience, 66, 121–127. DOI: https://doi.org/10.1007/s11060-020-03595-5
Blitshteyn, S., Crook, J, E., Jaeckle, K, A., (2008). Is There an Association Between Meningioma and Hormone Replacement Therapy? Journal of Clinical Oncology DOI: 10.1200/JCO.2007.14.2133
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492
Gritsch, S., Batchelor, T. T. & Gonzalez Castro, L. N., (2022). Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system. Cancer, 128(1), pp. 47-58. DOI: 10.1002/cncr.33918
Li, J. et al. (2019) ‘Prognostic value of Ki-67/MIB-1 expression in meningioma patients: A meta-analysis’, Critical Reviews in Eukaryotic Gene Expression, 29(2), pp. 141–150. DOI: 10.1615/CritRevEukaryotGeneExpr.2019025430
Nowosielski, M., (2017). Diagnostic challenges in meningioma. Neuro- Oncology, 19(12), pp. 1588-1598. DOI: 10.1093/neuonc/nox101
Ogasawara, C., Philbrick, B. D. & Adamson, D. C., (2021). Meningioma: A review of epidemiology, pathology, diagnosis, treatment, and future directions. Biomedicines, 9(3). DOI: 10.3390/biomedicines9030319
Passa, R. S., Nurmaini, S., Rini, D., P., (2023). Deteksi Tumor Otak Pada Magnetic Resonance Imaging Menggunakan YOLOv7., Jurnal Ilmiah MATRIK , Vol. 25 No.2
Pećina‐Šlaus, N., Kafka, A., Vladušić, T., Tomas, D., Logara, M., Skoko, J., & Hrašćan, R. (2016). Loss of p53 expression is accompanied by upregulation of beta‐catenin in meningiomas: a concomitant reciprocal expression. International Journal of Experimental Pathology, 97(2), 159-169. DOI: 10.1111/iep.12186
Wang, J. S., Wang, H. J., & Qian, H. L. (2018). Biological effects of radiation on cancer cells. Military Medical Research, 5, 1-10. DOI: https://doi.org/10.1186/s40779-018-0167-4
License
Copyright (c) 2023 Trisna Ayu Kurnia Putri, Lale Maulin Prihatin, Bambang Priyanto
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
